Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance

Biophysical Journal

Volumn 84, Issue 3, 2003, Pages 1450-1463

  Barreca, Maria L ^a   Lee, Keun Woo ^b   Chimirri, Alba ^a   Briggs, James M ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; INTEGRASE INHIBITOR; VIRUS ENZYME;

ARTICLE; BINDING SITE; COMPLEX FORMATION; DRUG DESIGN; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; NONHUMAN; VIRUS INFECTION; VIRUS RESISTANCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037339235     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(03)74958-3     Document Type: Article

References (59)

1. Abagyan, R. A., M. M. Totrov, and D. N. Kuznetsov. 1994. ICM - a new method for protein modeling and design. Applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15:488-506.
2. Amadei, A., A. B. Linssen, and H. J. Berendsen. 1993. Essential dynamics of proteins. Proteins. 17:412-425.
3. Anchell, J., E. Apra, D. Bernholdt, P. Borowski, E. Bylaska, T. Clark, D. Clerc, H. Dachsel, W. de Jong, M. Deegan, M. Dupuis, K. Dyall, D. Elwood, G. Fann, H. Fruchtl, E. Glendenning, M. Gutowski, R. Harrison, A. Hess, J. Jaffe, B. Johnson, J. Ju, R. Kendall, R. Kobayashi, R. Kutteh, Z. Lin, R. Littlefield, X. Long, B. Meng, J. Nichols, J. Nieplocha, A. Rendall, M. Rosing, G. Sandrone, M. Stave, T. P. Straatsma, H. Taylor, G. Thomas, J. van Lenthe, T. Windus, K, Wolinski, A. Wong, and Z. Zhang. 1999. NWChem, A Computational Chemistry Package for Parallel Computers, Version 3.3.1. High Performance Computational Chemistry Group, Pacific Northwestern National Laboratory, Richland, WA.
4. Asante-Appiah, E., and A. M. Skalka. 1999. HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv. Virus Res. 52:351-369.
5. Beese, L. S., and T. A. Steitz. 1991. Structural basis for the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. EMBO J. 10:25-33.
6. Berendsen, H. J. C., J. R. Grigerra, and T. P. Straatsma. 1987. The missing term in effective pair potentials. J. Phys. Chem. 91:6269-6271.
7. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
8. Bujacz, G., J. Alexandratos, Z. L. Qing, C. Clement-Mella, and A. Wlodawer. 1996. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. FEBS Lett. 398:175-178.
9. Bujacz, G., J. Alexandratos, A. Wlodawer, G. Merkel, M. Andrake, R. A. Katz, and A. M. Skalka. 1997. Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. J. Biol. Chem. 272:18161-18168.
10. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA. 89:6580-6584.
11. Bushman, F. D., A. Engelman, I. Palmer, P. Wingfield, and R. Craigie. 1993. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. USA. 90:3428-3432.
12. Cai, M., Y. Huang, M. Caffrey, R. Zheng, R. Craigie, G. M. Clore, and A. M. Gronenborn. 1998. Solution structure of the His12 → Cys mutant of the N-terminal zinc binding domain of HIV-1 integrase complexed to cadmium. Protein Sci. 7:2669-2674.
13. Cai, M., R. Zheng, M. Caffrey, R. Craigie, G. M. Clore, and A. M. Gronenborn. 1997. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat. Struct. Biol. 4:567-577.
14. Carlson, H. A., K. M. Masukawa, K. Rubins, F. D. Bushman, W. L. Jorgensen, R. D. Lins, J. M. Briggs, and J. A. McCammon. 2000. Developing a dynamic pharmacophore model for HIV-1 integrase. J. Med. Chem. 43:2100-2114.
15. Chen, Z., Y. Yan, S. Munshi, Y. Li, J. Zugay-Murphy, B. Xu, M. Witmer, P. Felock, A. Wolfe, V. Sardana, E. A. Emini, D. Hazuda, and L. C. Kuo. 2000. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293) - an initial glance of the viral DNA binding platform. J. Mol. Biol. 296:521-533.
16. Chow, S. A., K. A. Vincent, V. Ellison, and P. O. Brown. 1992. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science. 255:723-726.
17. Cornell, W. D., P. Cieplak, C. I. Bayly, I. R. Gould, K. M. Merz, Jr., D. M. Ferguson, D. C. Spellmeyer, T. Fox, J. W. Caldwell, and P. A. Kollman. 1995. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117:5179-5197.
18. De Clercq, E. 2000. Novel compounds in preclinical/early clinical development for the treatment of HIV infections. Rev. Med. Virol. 10:255-277.
19. Dyda, F., A. B. Hickman, T. M. Jenkins, A. Engelman, R. Craigie, and D. R. Davies. 1994. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 266:1981-1986.
20. Eijkelenboom, A, P., R. A. Lutzke, R. Boelens, R. H. Plasterk, R. Kaptein, and K. Hard. 1995. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat. Struct. Biol. 2:807-810.
21. Eijkelenboom, A. P., R. Sprangers, K. Hard, R. A. Puras Lutzke, R. H. Plasterk, R, Boelens, and R. Kaptein. 1999. Refined solution structure of the C-terminal DNA-binding domain of human immunovirus-1 integrase. Proteins. 36:556-564.
22. Engelman, A., and R. Craigie. 1992. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66:6361-6369.
23. Engelman, A., A. B. Hickman, and R. Craigie. 1994. The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J. Virol. 68:5911-5917.
24. Engelman, A., K. Mizuuchi, and R. Craigie. 1991. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell. 67:1211-1221.
25. Esposito, D., and R. Craigie. 1998. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 17:5832-5843.
26. Essmann, U., L. Perera, M. L. Berkowitz, T. Darden, H. Lee, and L. G. Pedersen. 1995. A smooth particle mesh Ewald method. J. Chem. Phys. 103:8577-8593.
27. Goldgur, Y., R. Craigie, G. H. Cohen, T. Fujiwara, T. Yoshinaga, T. Fujishita, H. Sugimoto, T. Endo, H. Murai, and D. R. Davies. 1999. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. USA. 96:13040-13043.
28. Goldgur, Y., F. Dyda, A. B. Hickman, T. M. Jenkins, R. Craigie, and D. R. Davies. 1998. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. USA. 95:9150-9154.
29. Greenwald, J., V. Le, S. L. Butler, F. D. Bushman, and S. Choe. 1999. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. Biochemistry. 38:8892-8898.
30. Harrison, R. J., J. Nichols, T. P. Straatsma, M. Dupuis, E. J. Bylaska, G. Fann, T. Windus, E. Apra, J. Anchell, J. D. Bernholdt, P. Borowski, T. Clark, D. Clerc, H. Dachsel, B. de Jong, M. Deegan, K. Dyall, D. Elwood, H. Fruchtl, E. Glendenning, M. Gutowski, A. Hess, J. Jaffe, B. Johnson, J. Ju, R. Kendall, R. Kobayashi, R. Kutteh, Z. Lin, R. Littlefield, X. Long, B. Meng, J. Nieplocha, S. Niu, M. Rosing, G. Sandrone, M. Stave, H. Taylor, G. Thomas, J. van Lenthe, K. Wolinski, A. Wong, and Z. Zhang. 2000. NWChem, A Computational Chemistry Package for Parallel Computers, Version 4.0. High Performance Computational Chemistry Group, Pacific Northwestern National Laboratory, Richland, WA.
31. Hazuda, D. J., P. Felock, M. Witmer, A. Wolfe, K. Stillmock, J. A. Grobler, A. Espeseth, L. Gabryelski, W. Schleif, C. Blau, and M. D. Miller. 2000. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science. 287:646-650.
32. Heuer, T. S., and P. O. Brown. 1997. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking. Biochemistry. 36:10655-10665.
33. Heuer, T. S., and P. O. Brown. 1998. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex. Biochemistry. 37:6667-6678.
34. Hockney, R. W., and J. W. Eastwood. 1981. Computer Simulations Using Particles. McGraw Hill, New York.
35. InsightII. 1999. Accelrys, Inc., San Diego, CA.
36. Jenkins, T. M., D. Esposito, A. Engelman, and R. Craigie. 1997. Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J. 16:6849-6859.
37. Kabsch, W., and C. Sander. 1983. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:2577-2637.
38. Koradi, R., M. Billeter, and K. Wuthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55.
39. Kulkosky, J., K. S. Jones, R. A. Katz, J. P. Mack, and A. M. Skalka. 1992. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 12:2331-2338.
40. Lee, S. P., J. Xiao, J. R. Knutson, M. S. Lewis, and M. K. Han. 1997. Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry. 36:173-180.
41. Lins, R. D., A. Adesokan, T. A. Soares, and J. M. Briggs. 2000. Investigations on human immunodeficiency virus type 1 integrase/DNA binding interactions via molecular dynamics and electrostatics calculations. Pharmacol. Ther. 85:123-131.
42. Lins, R. D., J. M. Briggs, T. P. Straatsma, H. A. Carlson, J. Greenwald, S. Choe, and J. A. McCammon. 1999. Molecular dynamics studies on the HIV-1 integrase catalytic domain. Biophys. J. 76:2999-3011.
43. Lodi, P. J., J. A. Ernst, J. Kuszewski, A. B. Hickman, A. Engelman, R. Craigie, G. M. Clore, and A. M. Gronenborn. 1995. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry. 34:9826-9833.
44. Madura, J. D., J. M. Briggs, R. C. Wade, M. E. Davis, B. A. Luty, A. Ilin, J. Antosiewicz, M. K. Gilson, B. Bagheri, L. R. Scott, and J. A. McCammon. 1995. Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian dynamics program. Comput. Phys. Commun. 91:57-95.
45. Maignan, S., J. P. Guilloteau, Q. Zhou-Liu, C. Clement-Mella, and V. Mikol. 1998. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J. Mol. Biol. 282:359-368.
46. McDonald, I. K., and J. M. Thornton. 1994. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238:777-793.
47. Molteni, V., J. Greenwald, D. Rhodes, Y. Hwang, W. Kwiatkowski, F. D. Bushman, J. S. Siegel, and S. Choe. 2001. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. Acta Crystallogr. D Biol. Crystallogr. 57:536-544.
48. Ni, H., C. A. Sotriffer, and J. A. McCammon. 2001. Ordered water and ligand mobility in the HIV-1 integrase-5CITEP complex: A molecular dynamics study. J. Med. Chem. 44:3043-3047.
49. Polard, P., and M. Chandler. 1995. Bacterial transposases and retroviral integrases. Mol. Microbiol. 15:13-23.
50. Ryckaert, J. P., G. Ciccitti, and H. J. C. Berendsen. 1977. Numerical integration of the cartesian equations of motion of a system with constrains: molecular dynamics of n-alkanes. J. Comp. Phys. 23:327-341.
51. Sotriffer, C. A., H. Ni, and J. A. McCammon. 2000. HIV-1 Integrase inhibitor interaction at the active site: prediction of binding modes unaffected by cristal packing. J. Am. Chem. Soc. 122:6136-6137.
52. Tsurutani, N., M. Kubo, Y. Maeda, T. Ohashi, N. Yamamoto, M. Kannagi, and T. Masuda. 2000. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J. Virol. 74:4795-4806.
53. van Gent, D. C., A. A. M. Oude Groeneger, and R. H. A. Plasterk. 1993. Identification of amino acids in HIV-2 integrase involved in site-specific hydrolysis and alcoholysis of viral DNA termini. Nucleic Acids Res. 21:3373-3377.
54. Vink, C., A. M. Oude Groeneger, and R. H. Plasterk. 1993. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type 1 integrase protein. Nucleic Acids Res. 21:1419-1425.
55. Vriend, G. 1990. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8:52-56.
56. Weber, W., H. Demirdjian, R. D. Lins, J. M. Briggs, R. Ferreira, and J. A. McCammon. 1998. Brownian and essential dynamics studies of the HIV-1 integrase catalytic domain. J. Biomol. Struct. Dyn. 16:733-745.
57. Wlodawer, A. 1999. Crystal structures of catalytic core domains of retroviral integrases and role of divalent cations in enzymatic activity. Adv. Virus Res. 52:335-350.
58. Yang, Z. N., T. C. Mueser, F. D. Bushman, and C. C. Hyde. 2000. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. J. Mol. Biol. 296:535-548.
59. Zheng, R., T. M. Jenkins, and R. Craigie. 1996. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. USA. 93:13659-13664.